05/13/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024
3:05 PM | Louis Chrystal (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:17 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:25 PM | BAKER BROS. ADVISORS LP (Filed by)
TScan Therapeutics (Subject)
| Form SC 13D/A | |
04/23/2024
3:15 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
8:58 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
|
04/17/2024
5:25 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
5:20 AM | TScan Therapeutics (Subject)
| Form FWP | |
04/16/2024
4:21 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
04/16/2024
3:16 PM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2024
11:15 PM | TScan Therapeutics (Filer)
| Form EFFECT | |
04/10/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-K/A | |
04/08/2024
7:17 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
6:30 AM | TScan Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:45 PM | K2 HealthVentures Equity Trust LLC (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
5:02 AM | Pitango HealthTech Fund I, L.P. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/07/2024
6:45 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/02/2024
3:21 PM | Amello Jason (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2023
4:00 PM | BARBERICH TIMOTHY J (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
5:01 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
7:00 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
7:15 AM | TScan Therapeutics (Issuer)
TScan Therapeutics (Issuer)
Woods Keith (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/08/2023
7:20 AM | TScan Therapeutics (Issuer)
TScan Therapeutics (Issuer)
Woods Keith (Reporting)
Woods Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
6:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2023
6:39 PM | Dworak Leiden (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
6:31 PM | Dworak Leiden (Reporting)
TScan Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/29/2023
7:30 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
3:38 PM | TScan Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/15/2023
5:25 PM | BARBERICH TIMOTHY J (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:01 PM | TScan Therapeutics (Issuer)
ZDRAVESKI ZORAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:08 PM | MacBeath Gavin (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:09 PM | Silver Brian M. (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:13 PM | Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:14 PM | Gruia Gabriela (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Elon to Transform U.S. Economy? (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. |
06/15/2023
5:17 PM | Dorton Katina (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:19 PM | Barton Debora (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:40 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
12:25 PM | BlackRock Inc. (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G/A | |
06/06/2023
6:53 PM | BARBERICH TIMOTHY J (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:45 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
TScan Therapeutics (Subject)
| Form SC 13G | |
06/02/2023
4:33 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/02/2023
4:35 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
7:00 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2023
7:16 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/26/2023
7:12 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
05/26/2023
5:42 AM | TScan Therapeutics (Subject)
| Form FWP | |
05/17/2023
7:15 AM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2023
11:15 PM | TScan Therapeutics (Filer)
| Form EFFECT | |
05/16/2023
11:15 PM | TScan Therapeutics (Filer)
| Form EFFECT | |
05/16/2023
4:19 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
05/16/2023
4:21 PM | TScan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
3:42 PM | SOUTHWELL DAVID P (Reporting)
TScan Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
